High Specificity and Purity
Directed evolution ensures the Dimerization Enzyme produces only the desired active isomer, solving the low activity problem from chemical mixtures.
Lutein Dimer ( Lutein Epoxide Dimer or other functionalized Lutein dimers ) is a promising carotenoid derivative with potentially enhanced antioxidant properties for the pharmaceutical and cosmetic industries. Current production methods, often relying on semi-synthesis from naturally sourced Lutein , involve multiple steps in chemical synthesis . These steps are inefficient, generate toxic waste, and lack stereoselectivity. The resulting product often exhibits low activity due to contamination with inactive isomers and impurities generated during the harsh chemical process. Biosynthesis offers a superior, greener, and more stereoselective alternative.
CD Biosynsis offers a synthetic biology service focused on the clean and efficient production of specific Lutein Dimers using Escherichia coli ( E. coli ). Our core strategy begins with modification of lutein synthesis pathway in Escherichia coli . This involves engineering E. coli 's native central metabolism ( Glycolysis and MEP Pathway ) to boost the supply of the Isoprenoid precursor ( IPP ), followed by the heterologous expression and optimization of the complete Lutein pathway ( CrtE , B , I , Y , Z , E etc.) to maximize the concentration of the Lutein intermediate. The key innovation is the directed evolution of dimerization enzyme . We introduce a specific enzyme ( e.g. , a novel oxidase or coupling synthase ) that catalyzes the selective dimerization of Lutein or its functionalized derivatives. We then apply directed evolution techniques ( error - prone PCR , DNA shuffling ) to this enzyme to dramatically enhance its catalytic efficiency and stereoselectivity for the desired Dimer isomer . This integrated approach solves the multiple steps in chemical synthesis challenge by replacing it with a single, highly selective enzymatic step, ensuring the production of the isomer with the highest activity and purity.
Get a QuoteDeveloping a high-quality Lutein Dimer product faces these key challenges:
A successful solution must ensure robust Lutein production and introduce a highly selective, optimized dimerization biocatalyst.
CD Biosynsis utilizes advanced metabolic and enzyme engineering to optimize Lutein Dimer production in E. coli :
Modification of Lutein Synthesis Pathway in E. coli
We upregulate the native MEP pathway and co-express the complete heterologous Lutein gene cluster ( CrtE , B , I , Y , Z , E ) for maximal Lutein precursor supply.
Directed Evolution of Dimerization Enzyme
We apply high - throughput screening and mutagenesis to a promising Dimerization Enzyme to enhance its catalytic activity and regioselectivity for the Lutein Dimer .
Metabolic Precursor Optimization
We delete competing central metabolism pathways ( e.g. , acetate production pathway ) to ensure maximum carbon flux is directed into the MEP pathway.
Enzyme Compartmentalization
We use protein scaffolds or microcompartments to co-localize Lutein pathway enzymes and the Dimerization Enzyme , enhancing metabolic efficiency.
This systematic approach ensures high Lutein supply and a highly specific enzymatic conversion to the Dimer .
Our Lutein Dimer engineering service is dedicated to pursuing the following production goals:
High Specificity and Purity
Directed evolution ensures the Dimerization Enzyme produces only the desired active isomer, solving the low activity problem from chemical mixtures.
Simplified Production Process
Replacing multiple steps in chemical synthesis with a single biological step streamlines manufacturing, reduces waste, and lowers costs.
High Volumetric Productivity Icon
Optimized MEP and Lutein pathways ensure high Lutein titer as the precursor, maximizing the final Dimer yield.
Enhanced Bioactivity Icon
Production of a high-purity, specific isomer ensures the maximal therapeutic and cosmetic effect of the Lutein Dimer .
Green Synthesis Route Icon
Microbial fermentation is an environmentally friendly alternative, avoiding toxic solvents and harsh conditions of chemical synthesis.
We provide a sustainable, high-performance, and high-purity biosynthetic route for Lutein Dimer .
Our Lutein Dimer strain engineering service follows a rigorous, multi-stage research workflow:
Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and product specificity.
Explore the potential for a stable, highly active Lutein Dimer supply. CD Biosynsis provides customized strain and enzyme engineering solutions:
Why is Directed Evolution needed for the dimerization enzyme?
Natural enzymes may have low activity or poor selectivity for a novel substrate like Lutein Dimer . Directed evolution rapidly mutates and screens the enzyme to artificially evolve it to be highly efficient and selective for the specific, desired dimerization reaction, overcoming the low activity challenge.
How does biosynthesis simplify the chemical process?
Chemical synthesis of dimers involves multiple harsh steps ( oxidation , coupling , purification ). Biosynthesis replaces all these steps with a single, highly selective enzymatic reaction inside the cell, significantly reducing the complexity, time, and cost.
What is the challenge with the Lutein pathway in E. coli ?
Lutein synthesis requires seven or more heterologous genes ( Crt cluster ) to be co-expressed, and the reaction intermediates are prone to degradation. Optimizing the expression levels and ensuring maximal flux through all steps is a major metabolic engineering challenge.
Why is E. coli chosen over Yeast for this product?
E. coli has a highly active MEP pathway for Isoprenoid precursor supply, often leading to higher carotenoid titers than the MVA pathway in yeast. It is also an easily manipulated host for large-scale fermentation.
What is the estimated project timeline?
A project involving multi-gene pathway construction, enzyme identification, and extensive directed evolution typically requires 26-30 weeks for final strain delivery and comprehensive performance validation.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.